Key facts
- It has raised $1.0M.
- Notable investors include Arben Ventures, Exceptional Ventures, Headstream, Elise Houren, Helsinki Incubators — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for ReMinded
- ·The full record, as it builds
Funding rounds
No funding rounds for ReMinded are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ReMinded
Developer of a portable device designed to quantitatively measure cortisol in saliva to support improved outcomes in mental healthcare and stress-related conditions. The company offers salivary biomarker analysis and rapid access to cortisol data, enabling clinicians and patients in mental healthcare and stress-related care to monitor physiological patterns and inform care decisions.
- Sector
- Healthcare
- HQ
- NY
- Founded
- 2023
- Employees
- 7
- Website
- remindedhealth.com/
- Ownership
- Privately Held (backing)
ReMinded doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ReMinded shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ReMinded in its N-PORT filings yet. We sweep new filings monthly.